Introduction:

Drug-induced uveitis is a form of ocular inflammation that arises as a result of certain medications' use. Uveitis involves inflammation of the uvea, the middle layer of the eye, which can lead to pain, redness, and potential vision impairment. In this comprehensive article, we delve into the causes, symptoms, diagnosis, treatment, and management of drug-induced uveitis.

Causes:

Several medications have been associated with drug-induced uveitis. Some of the common culprits include:

• Topiramate: An anticonvulsant and migraine prophylactic.
• Sulfonamides: Antibiotics used to treat various infections.
• Rifabutin and Rifampin: Antibiotics employed to treat tuberculosis and other infections.
• Bisphosphonates: Medications prescribed for osteoporosis and certain bone-related diseases.
• Infliximab, Adalimumab, Etanercept: Anti-TNF agents used for inflammatory conditions like rheumatoid arthritis and Crohn's disease.
• Moxifloxacin and Ciprofloxacin: Antibiotics for various infections.
• Other Medications: Certain other drugs like certain diuretics, anti-epileptics, and immunomodulators have also been linked to drug-induced uveitis.

Symptoms:

The symptoms of drug-induced uveitis are similar to those of other types of uveitis and may include:

• Eye redness and pain.
• Blurred vision or visual disturbances.
• Light sensitivity (photophobia).
• Floaters or dark spots in the field of vision.
• Eye discomfort or irritation.

Diagnosis:

Diagnosing drug-induced uveitis involves a comprehensive eye examination, and a thorough medical history, including current medication usage. Additional diagnostic tests may include:

• Slit-Lamp Biomicroscopy: An examination of the eye using a specialized microscope to assess the anterior segment, where uveitis often presents.
• Ophthalmoscopy: Examination of the interior of the eye, including the retina and optic nerve.
• Visual Acuity Test: Assessing how well the patient sees at various distances.
• Inflammatory Markers: Blood tests to detect signs of inflammation.
• Optical Coherence Tomography (OCT): Imaging test to evaluate the retina and optic nerve.
• Fluorescein Angiography: A dye-based test to assess blood flow in the retina and choroid.
• Indocyanine Green Angiography: A test similar to fluorescein angiography but using a different dye.

Treatment:

The primary treatment goal for drug-induced uveitis is to discontinue the offending medication, if possible. Additional treatment options may include:

• Topical Corticosteroids: Eye drops or ointments containing corticosteroids to reduce inflammation.
• Oral Corticosteroids: In severe cases, systemic corticosteroids may be prescribed.
• Immunomodulatory Therapy: For refractory cases, immunosuppressive agents may be considered.
• Cycloplegic Eye Drops: To alleviate pain and reduce the risk of complications like synechiae formation.
• Close Monitoring: Regular follow-up appointments with an ophthalmologist to monitor progress and adjust treatment as needed.

Management:

For patients with a history of drug-induced uveitis, careful medication selection, and monitoring are crucial. Healthcare providers should be informed about previous episodes to avoid medications that could trigger recurrence.

Conclusion:

Drug-induced uveitis is an important consideration for healthcare professionals when evaluating ocular inflammation in patients taking specific medications. Identifying the causative medication, promptly discontinuing it, and implementing appropriate treatment strategies can lead to favorable outcomes. Close monitoring and communication between patients and healthcare providers play a key role in managing drug-induced uveitis effectively.

Hashtags: #DrugInducedUveitis #OcularInflammation #UveitisCauses #EyeHealth #MedicationSideEffects